Literature DB >> 7128663

Pharmacokinetic and pharmacodynamic studies of tienilic acid in healthy volunteers.

A L Kerremans, F W Gribnau, Y Tan, C A van Ginneken.   

Abstract

A simple and reliable HPLC method for the determination of tienilic acid ((TA) Selacryn, Selcryn, Diflurex, Ticrynafen) and its alcoholic metabolite in plasma and urine has been developed. In 8 healthy adult volunteers the plasma and urinary levels of tienilic acid and its alcoholic metabolite, and plasma and urinary levels of sodium, creatinine and uric acid were measured after oral administration of tienilic acid 250 mg. The pharmacokinetic parameters found differed only slightly from those reported in the literature, as there was faster absorption and a shorter half-life. TA is probably excreted by a saturable renal tubular transport mechanism. The pharmacodynamic effects of tienilic acid developed quickly, the uricosuric effect being very impressive and the natriuretic effect moderate. These effects disappeared in about 8 h. An inverse relationship was found between the starting plasma uric acid level in an individual and the maximal uric acid clearance - the higher the plasma uric acid level, the lower was the maximum effect. Plasma tienilic acid level and natriuretic effect were correlative within individuals and intra-individually (p less than 0.05). Urinary tienilic acid level and natriuretic effect were correlated, too (p less than 0.05 to p less than 0.001), but only intraindividually. No correlation between drug level and uricosuric effect was found.

Entities:  

Mesh:

Substances:

Year:  1982        PMID: 7128663     DOI: 10.1007/bf00609624

Source DB:  PubMed          Journal:  Eur J Clin Pharmacol        ISSN: 0031-6970            Impact factor:   2.953


  12 in total

1.  Total ban on tienilic acid.

Authors:  F O Simpson; H J Waal-Manning
Journal:  Lancet       Date:  1980-05-03       Impact factor: 79.321

2.  A direct colorimetric determination of uric acid in serum and urine with uricase-catalase system.

Authors:  N Kageyama
Journal:  Clin Chim Acta       Date:  1971-02       Impact factor: 3.786

3.  Effect of probenecid on excretion and natriuretic action of furosemide.

Authors:  F Andreasen; B Sigurd; E Steiness
Journal:  Eur J Clin Pharmacol       Date:  1980-11       Impact factor: 2.953

4.  Ticrynafen: kinetics, protein binding, and effects on serum and urinary uric acid.

Authors:  A J Wood; P Bolli; H J Waal-Manning; F O Simpson
Journal:  Clin Pharmacol Ther       Date:  1978-06       Impact factor: 6.875

5.  Ticrynafen's withdrawal from the market.

Authors:  W R Barclay
Journal:  JAMA       Date:  1980 Feb 22-29       Impact factor: 56.272

6.  Mechanism of the uricosuric activity of ticrynafen.

Authors:  T H Steele
Journal:  Nephron       Date:  1979       Impact factor: 2.847

7.  Ticrynafen and hydrochlorothiazide. A double-blind study of antihypertensive properties with an open crossover.

Authors:  S A Miller; V Vertes
Journal:  JAMA       Date:  1979-05-18       Impact factor: 56.272

8.  Ticrynafen: a novel uricosuric antihypertensive natriuretic agent.

Authors:  J G de Carvalho; F G Dunn; S G Chrysant; E D Frohlich
Journal:  Arch Intern Med       Date:  1978-01

9.  Tienilic acid: pharmacokinetics, salicylate interaction and creatinine secretion studies.

Authors:  J W Dubb; R M Stote; A R Maass; B V Hwang; R G Familiar; F Alexander
Journal:  Postgrad Med J       Date:  1979       Impact factor: 2.401

10.  Renal handling of urate in healthy man in hyperuricaemia and renal insufficiency: circadian fluctuation, effect of water diuresis and of uricosuric agents.

Authors:  F Lang; R Greger; H Oberleithner; E Griss; K Lang; D Pastner; P Dittrich; P Deetjen
Journal:  Eur J Clin Invest       Date:  1980-08       Impact factor: 4.686

View more
  1 in total

Review 1.  Saturable pharmacokinetics in the renal excretion of drugs.

Authors:  C A van Ginneken; F G Russel
Journal:  Clin Pharmacokinet       Date:  1989-01       Impact factor: 6.447

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.